Una revisión en ‘Science’ repasa la nueva generación de fármacos contra la obesidad. También avisa de que las patentes de los genéricos de semaglutida retrasarán su llegada a España hasta 2031, pese a que ya se venden en India y Brasil
Excerpt from El País. Original publication ↗
Source: El País
It’s the first measles death in the state since 1990.
A future Wallabies hopeful has endured more than most by his age. Those setbacks have steeled him to challenge one of Australian rugby’s brightest stars.
The global health and economic benefits of the covid-19 vaccines were thought to have reached up to $38 trillion in their first year, but a new analysis suggests $64.3 trillion is a more accurate figure
Changes to insurance coverage have seen people paying more, or choosing cheaper, less effective options.